Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sore, Sophie"'
Autor:
Viaud, Manon, Abdel-Wahab, Omar, Gall, Julie, Ivanov, Stoyan, Guinamard, Rodolphe, Sore, Sophie, Merlin, Johanna, Ayrault, Marion, Guilbaud, Emma, Jacquel, Arnaud, Auberger, Patrick, Wang, Nan, Levine, Ross L., Tall, Alan R., Yvan-Charvet, Laurent
Publikováno v:
In Cell Reports 10 March 2020 30(10):3397-3410
Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia
Autor:
Saint-Laurent, Celine, Garcia, Stephanie, Sarrazy, Vincent, Dumas, Karine, Authier, Florence, Sore, Sophie, Tran, Albert, Gual, Philippe, Gennero, Isabelle, Salles, Jean-Pierre, Gouze, Elvire
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195876 (2018)
PLoS ONE
PLoS ONE
Background Achondroplasia is a rare genetic disease is characterized by abnormal bone development and early obesity. While the bone aspect of the disease has been thoroughly studied, early obesity affecting approximately 50% of them during childhood
Autor:
Sarrazy, Vincent, Sore, Sophie, Viaud, Manon, Rignol, Guylène, Westerterp, Marit, Ceppo, Franck, Tanti, Jean-François, Guinamard, Rodolphe r., Gautier, Emmanuel L., Yvan-Charvet, Laurent
Publikováno v:
Cell Reports
Cell Reports, 2015, 13 (1), pp.132-144. ⟨10.1016/j.celrep.2015.08.068⟩
Cell Reports, Elsevier Inc, 2015, 13 (1), pp.132-144. ⟨10.1016/j.celrep.2015.08.068⟩
Cell reports, 13(1), 132-144. CELL PRESS
Cell Reports, Vol 13, Iss 1, Pp 132-144 (2015)
Cell Reports, 2015, 13 (1), pp.132-144. ⟨10.1016/j.celrep.2015.08.068⟩
Cell Reports, Elsevier Inc, 2015, 13 (1), pp.132-144. ⟨10.1016/j.celrep.2015.08.068⟩
Cell reports, 13(1), 132-144. CELL PRESS
Cell Reports, Vol 13, Iss 1, Pp 132-144 (2015)
International audience; Enhanced glucose utilization can be visualized in atherosclerotic lesions and may reflect a high glycolytic rate in lesional macrophages, but its causative role in plaque progression remains unclear. We observe that the activi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::035a43cfb378cad593dae2af5c8ac7d3
https://hal.science/hal-03798234
https://hal.science/hal-03798234
Autor:
Sarrazy V; Institut National de la Santé et de la Recherche Médicale (INSERM) U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, 06204 Nice, France., Sore S; Institut National de la Santé et de la Recherche Médicale (INSERM) U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, 06204 Nice, France., Viaud M; Institut National de la Santé et de la Recherche Médicale (INSERM) U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, 06204 Nice, France., Rignol G; Institut National de la Santé et de la Recherche Médicale (INSERM) U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, 06204 Nice, France., Westerterp M; Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY 10032, USA., Ceppo F; Institut National de la Santé et de la Recherche Médicale (INSERM) U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, 06204 Nice, France., Tanti JF; Institut National de la Santé et de la Recherche Médicale (INSERM) U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, 06204 Nice, France., Guinamard R; Institut National de la Santé et de la Recherche Médicale (INSERM) U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, 06204 Nice, France., Gautier EL; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR_S 1166, Pierre and Marie Curie University Paris 6, ICAN Institute of Cardiometabolism and Nutrition, 75006 Paris, France., Yvan-Charvet L; Institut National de la Santé et de la Recherche Médicale (INSERM) U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, 06204 Nice, France. Electronic address: laurent.yvan-charvet@unice.fr.
Publikováno v:
Cell reports [Cell Rep] 2015 Oct 06; Vol. 13 (1), pp. 132-144. Date of Electronic Publication: 2015 Sep 24.